Epidemiology of malaria and leishmaniasis in Thailand (2004–2025): A systematic review Authors: Warachaya Apajamjarut, Nalin Siriwongsanon, Patanin Tonpon, Lapatrada Boonlertworakul, Ruamporn Joosiriwong, Baby Kyi Soe, Saowalak Kaewmee, Jassada Saingamsook, Catherine Walton, Sung Jae Lee, Chunqing Lin, George Dimopoulos, Narissara Jariyapan Published: 2026 ABSTRACT AbstractMalaria and leishmaniasis remain major vector-borne parasitic diseases in tropical and subtropical regions. The aim of this systematic review was to synthesize evidence on the epidemiology and shared ecological and epidemiological characteristics of malaria and leishmaniasis in Thailand from 2004 to 2025. This systematic review was conducted in accordance with PRISMA guidelines and utilized three databases, PubMed, Scopus, and ScienceDirect, supplemented by grey literature and manual reference screening. From 1397 records, a total of 57 studies were included (36 on malaria and 21 on leishmaniasis). Malaria transmission persisted mainly in border and forest-associated areas, with nine Plasmodium species documented in Thailand across the included studies, including the emerging zoonotic parasites (Plasmodium knowlesi and Plasmodium cynomolgi). Plasmodium vivax and Plasmodium falciparum predominated nationwide; however, P. falciparum has shown a declining trend since 2012. Leishmaniasis was reported across multiple regions, with six Leishmania species identified. Leishmania martiniquensis and Leishmania orientalis were predominant species among people living with HIV. Seven provinces had reported occurrences of both diseases across the overall review period, associated with shared ecological conditions, forest-related occupational exposure, and population mobility. However, such findings reflect province-level co-occurrence based on aggregated evidence rather than confirmed concurrent transmission or co-infection. These findings highlight epidemiological characteristics and shared risk factors, particularly among immunocompromised populations and individuals engaged in forest-related activities. Integrated surveillance and control strategies within a One Health framework may strengthen the ability to eliminate malaria transmission and the expanding burden of leishmaniasis in Thailand.Keywords: Malaria, Plasmodium, Leishmaniasis, Leishmania, Co-occurrence, Thailand Introduction Malaria and leishmaniasis, major parasitic and vector-borne diseases, have raised global health concerns, particularly in tropical and subtropical regions. Malaria is caused by protozoan parasites belonging to the genus Plasmodium and transmitted through the infectious bite of female Anopheles vector mosquitoes. Traditionally, five Plasmodium species, including P. falciparum, P. vivax, P. malariae, P. ovalecurtisi (formerly called P. ovale, “classic” form), P. ovalewallikeri (formerly called P. ovale wallikeri, “variant” form), have been recognized as major causes of human malaria (Snounou et al., 2024). However, increasing evidence has established P. knowlesi as an important zoonotic malaria parasite capable of naturally infecting humans, particularly in Southeast Asia (White, 2008). Urban expansion and more convenient and frequent travel have brought humans into closer contact with wildlife by destroying natural habitats, creating shared “edge” environments, and providing easy access to remote areas, which together increase opportunities for pathogens to spillover from wildlife to humans (Hassell et al., 2017; Esposito et al., 2023). Consequently, P. knowlesi has emerged as an important zoonotic malaria infection agent affecting humans in recent decades. The initial symptom of malaria patients is fever. The timing of the fever is irregular depending on malaria parasite species, with some causing fever spikes every 48 h, while others may have a more irregular pattern. Other early symptoms are non-specific, such as chills, headache, myalgia, and gastrointestinal manifestations, making it difficult to distinguish them from other febrile illnesses. Untreated malaria can rapidly progress to severe disease, particularly in infections caused by P. falciparum. Severe malaria commonly presents with neurological impairment (e.g. altered consciousness or seizures), profound anemia, respiratory distress, and multi-organ dysfunction, including hepatic and renal failure. In advanced cases, circulatory collapse and extreme weakness may occur (Trampuz et al., 2003). The spectrum of clinical disease from P. knowlesi infection ranges from asymptomatic infection through severe malaria and death. Plasmodium knowlesi exhibits a 24-h erythrocytic cycle, resulting in rapid elevations in parasitemia and acute clinical advancement. Although most cases are uncomplicated, severe disease resembling P. falciparum malaria may occur. Current treatment in Thailand follows the Clinical Practice Guidelines for the Treatment of Malaria for Physicians, Thailand (Clinical Practice Guidelines, 2025). Malaria treatment depends on the infecting Plasmodium species, disease severity, and local epidemiological context. For example, uncomplicated P. falciparum malaria is typically treated with artemisinin-based combination therapies (ACTs), while chloroquine followed by primaquine remains effective in uncomplicated P. vivax malaria (Clinical Practice Guidelines, 2025). Human malaria has been affecting many countries around the world for centuries. Various strategies have been employed to eliminate malaria, for example, early detection and prompt treatment, mass drug administration campaigns, vector control, surveillance and monitoring, and community engagement. In Thailand, progress has been made but complete elimination of human malaria remains unachieved (Sattabongkot et al., 2022; Oo et al., 2025). Leishmaniasis, a zoonotic vector-borne disease, is caused by protozoan parasites of the genus Leishmania, transmitted through the bites of Leishmania-infected sand flies. The disease can manifest in various forms, including cutaneous leishmaniasis (CL), visceral leishmaniasis (VL), and mucocutaneous leishmaniasis (MCL). Currently, over 21 species of Leishmania have been documented as human pathogens, and more than 90 sand fly species, mainly phlebotomine sand flies (genus Phlebotomus in the Old World and Lutzomyia in the New World), are known to transmit Leishmania parasites (Hong et al., 2020). Humans are considered incidental hosts, whereas approximately 70 animal species serve as reservoirs for Leishmania parasites, for example, dogs, rodents, marsupials, and bats (Azami-Conesa et al., 2021). A combination of strategies, such as integrated vector management (IVM), the introduction of liposomal amphotericin B, and the improvement of welfare, has contributed to the control of leishmaniasis. These strategies can be used by other countries to achieve the same results (Nagi, 2024). However, drug-resistant Leishmania parasites have been identified, including miltefosine-resistant L. donovani and amphotericin B-resistant L. amazonensis. Amphotericin B-resistant L. martiniquensis have been documented (Srivastava et al., 2017; Mano et al., 2023a, 2023b; Ferreira et al., 2024; Jariyapan et al., 2025). Additionally, during the past 20 years, four new Leishmania spp. have emerged as human pathogens, i.e. L. (Mundinia) martiniquensis, L. (Mundinia) orientalis, L. (Mundinia) chancei, and L. (Leishmania) ellisi (Jariyapan et al., 2018; Kwakye-Nuako et al., 2023; Sapp et al., 2024). Furthermore, no vaccines are available for leishmaniasis, making the disease still a public health problem (WHO, 2023). Malaria and leishmaniasis may co-occur in settings where their endemic ranges or risk environments overlap, particularly in regions characterized by forest exposure and vector presence. In Yemen and Nepal, malaria and Leishmania co-infection cases have been reported (Bin Mohanna, 2015; Ghimire et al., 2019). In Malaysia, reported cases of co-infection have primarily involved imported infections among migrant workers rather than confirmed local transmission of leishmaniasis (Ab Rahman and Abdullah, 2011). It poses an important obstacle to the accurate diagnosis and timely treatment of both diseases. In Thailand, malaria remains a considerable health problem despite the significant progress in malaria control and elimination. Furthermore, indigenous leishmaniasis has been documented in several regions around the country. However, information regarding the shared ecological and epidemiological characteristics of malaria and leishmaniasis in Thailand is limited, despite reports of both diseases in several provinces. Therefore, an updated and comprehensive synthesis of available evidence is needed to better characterize their epidemiology, associated risk factors, and reported occurrence in Thailand. Therefore, this systematic review aims to (i) synthesize evidence on the prevalence, incidence, and epidemiological characteristics of malaria and leishmaniasis in Thailand between 2004 and 2025; (ii) characterize parasite species diversity, transmission settings, and factors associated with disease occurrence; and (iii) comparatively examine shared ecological and epidemiological characteristics of both diseases, including reported occurrence, at-risk populations, and environmental and occupational risk factors. By integrating findings across multiple study designs, this review seeks to clarify similarities and differences in the epidemiological profiles of malaria and leishmaniasis, identify surveillance gaps, and inform evidence-based strategies for integrated disease monitoring and control in Thailand. Materials and methods Protocol and registration The review protocol for this systematic review was registered on the Open Science Framework (OSF) (https://doi.org/10.17605/OSF.IO/C36JG). This systematic review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Page et al., 2021). Search strategy A comprehensive systematic literature search was undertaken to identify studies reporting the prevalence, epidemiological characteristics, and occurrence of malaria and leishmaniasis in Thailand published between January 2004 and December 2025. The selected period (2004–2025) was chosen to capture the declining trend and epidemiological transition of malaria, and the emergence and increasing recognition of leishmaniasis in Thailand. A structured search strategy was applied across three electronic biomedical databases: PubMed, Scopus, and ScienceDirect. Database searches were conducted between January and February 2026. The search strategy combined free-text keywords and text word searching. (Leishmania[tw] OR Malaria[tw] OR Plasmodium[tw]) AND (Prevalence[tw] OR Surveillance[tw] OR Case[tw]) AND Thailand[tw] was used to search in PubMed. In Scopus and ScienceDirect, the search strategy was: (Leishmania OR Malaria OR Plasmodium) AND (Prevalence OR Surveillance OR Case) AND Thailand. To ensure comprehensive coverage, additional sources were consulted, including grey literature, and manual screening of reference lists from relevant articles. This multi-source approach was applied to minimize publication bias and to capture studies not indexed in the selected databases. Eligibility criteria Studies were eligible for inclusion if they met the following predefined inclusion criteria: (i) articles published between January 2004 and December 2025; (ii) available in full text; (iii) written in English; (iv) employed observational study designs, including cross-sectional, case-control, and cohort studies (prospective or retrospective), as well as descriptive studies (e.g. case reports), and observational studies encompassing longitudinal and ecological approaches, some of which were based on routine surveillance data, reporting malaria and/or leishmaniasis in Thailand; (v) provided at least one of the following: prevalence of malaria and/or leishmaniasis infection in a defined population, positivity rate among symptomatic patients (with confirmation of active infection), parasite species identified among confirmed cases, diagnostic test, or included information on study location (province or region). Studies were excluded if they were clinical trials, reviews, editorials, or conference abstracts; lacked full-text availability; were published in languages other than English; focused exclusively on insects or animal hosts without human data; or contained overlapping or duplicate datasets. Study selection All identified studies from database searches were imported into Rayyan (https://www.rayyan.ai) (Ouzzani et al., 2016) for reference management; subsequently, duplicates were removed. Five independent reviewers (WA, NS, PT, LB, and RJ) screened titles and abstracts against pre-defined inclusion criteria. Studies deemed eligible proceeded to full-text assessment. Any disagreements were addressed through discussion; when consensus could not be reached, arbitration was provided by senior reviewers (BKS, NJ). The study selection process is summarized in a PRISMA flow diagram (Fig. 1). PRISMA flowchart summarizing the literature search strategy and study selection process used in this systematic review. Quality assessment Methodological quality was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist for case reports (Moola et al., 2020), prevalence studies (Munn et al., 2015), and cohort studies (Moola et al., 2020). Risk of bias assessment was independently conducted by three reviewers (BKS, SK, and NJ). Any discrepancies were resolved through discussion, and study authors were contacted when clarification was required. All appraisal outcomes were recorded using three response options: “Yes,” “No,” or “Unclear.” Each study was evaluated based on key domains of the appraisal tool. An overall score for each study was calculated using the following formula: (Total number of “Yes” responses ÷ Total number of appraisal items) × 100. Based on this score, studies were classified as having a low risk of bias (≥ 70%), a moderate risk of bias (50–69%), or a high risk of bias (< 50%). Studies assessed as having a high risk of bias were excluded from the final synthesis. Data extraction and qualitative synthesis To address the review objectives, data were systematically extracted from all included studies using a standardized data extraction form developed in Microsoft Excel. Extracted variables included: (i) type of infection (malaria or leishmaniasis); (ii) period of data collection; (iii) sample size and reported prevalence or incidence; (iv) study location and reported occurrence at regional and provincial levels; (v) characteristics of the study population/case (age, sex, socioeconomic or occupational background, and immune status, where available); and (vi) reported/suggested factors associated with disease occurrence, such as climate conditions, land use, human mobility, and vector control interventions, where available. It should be acknowledged that malaria data represent a robust national reporting system, while leishmaniasis data are heavily weighted toward high-risk groups, i.e. people living with HIV (PLHIV), and specific research sites like Trang Province. Data extraction was independently performed by five authors (WA, NS, PT, LB, and RJ) and subsequently cross-checked by additional authors (BKS, SK, and NJ) to ensure accuracy and consistency. Results were presented descriptively using summary tables and maps to illustrate reported occurrence patterns and epidemiological trends of malaria and leishmaniasis in Thailand from 2004 to 2025. Where quantitative data pooling was not appropriate because of substantial heterogeneity across studies, results were synthesized qualitatively without statistical aggregation. Results Characteristics of included studies The initial database search yielded a total of 1397 records. After a full-text review, a total of 57 studies were included in the qualitative synthesis (Supplementary Table S1). Of these, 36 studies investigated malaria and 21 addressed leishmaniasis. While the number of studies for each disease was comparable, the nature of the evidence differed. Malaria research predominantly utilized extensive longitudinal datasets, including longitudinal and ecological studies, and cohort studies, whereas the evidence base for leishmaniasis was more varied, primarily comprising case reports and cross-sectional studies, frequently targeting high-risk populations such as PLHIV. The included studies comprised a range of observational designs, including case reports (n = 24), cross-sectional studies (n = 17), case-control studies (n = 2), cohort studies (n = 9), longitudinal and ecological studies (n = 4), and a combined cross-sectional and cohort study (n = 1) (Supplementary Table S1). Geographically, the studies covered multiple regions of Thailand, with the largest proportion addressing the northern (n = 26) and southern (n = 20) regions. Additional studies were conducted in the western (n = 7), eastern (n = 7), central (n = 6), and northeastern (n = 5) regions. Overall, the included studies largely focused on areas with sustained malaria transmission and emerging leishmaniasis. Most included studies were assessed as having low risk of bias, with only one study, Sermwittayawong et al. (2015), classified as moderate risk (Supplementary Tables S2–S4). Malaria in Thailand (2004–2025) Study characteristics and parasite diversity A total of 36 studies were identified from 2004 to 2025, comprising case reports (n = 9) of human and zoonotic malaria (Table 1) and 27 studies (Table 2) representing cross-sectional studies (n = 13), case-control studies (n = 1), cohort studies (n = 8), longitudinal and ecological studies (n = 4), and a combined cross-sectional and cohort study (n = 1) (Supplementary Table S1). Nine species of Plasmodium, including P. falciparum, P. vivax, P. malariae, P. ovalecurtisi (P. ovale, “classic” form), P. ovalewallikeri (P. ovale wallikeri, “variant” form), P. inui, P. fieldi, P. knowlesi, and P. cynomolgi, were reported during the past 20 years (Table 1, Table 2). Five case reports described human malaria infections caused by P. falciparum and P. vivax, whereas four reports described zoonotic malaria infections, including P. knowlesi and P. cynomolgi (Table 1). Table 1Case reports of human and zoonotic malaria infection in Thailand (2004–2025).Table 1IDReference [Study year]Province [Region]SpeciesDiagnostic methodsCharacteristics of the study case (sex, age, occupation)TreatmentReported/suggested factors associated with disease occurrenceHuman malaria1Lwin et al. (2008) [NR]Tak [N]P. falciparumLMMale; 28 years-old; NRArtesunate and mefloquineResidence near Thailand-Myanmar border (forest/border exposure)2Luvira et al. (2009) [2008]Kanchanaburi [W]P. falciparumLMMale; 43 years-old; NRArtesunate and mefloquineTravel history to a forested area along the Thailand-Myanmar border prior to illness3Rijken et al. (2011) [2008]Tak [N]P. vivaxLM, PCRPregnant female; 38 years-old; NRChloroquine, dihydroartemisinin-piperaquine and primaquineLiving and working in forested areas along the Thailand-Myanmar border; chloroquine-resistant P. vivax malaria4Changpradub and Mungthin (2014) [NR]Sakon Nakhon [NE]P. vivaxLM, PCRMale; 24 years-old; painterArtesunate and mefloquineHistory of hunting activity in forested areas (Pupan Mountain) in Sakon Nakhon Province5Boonyarangka et al. (2022) [2021]Ratchaburi [C]P. vivaxRDT, PCRMale; 25 years-old; resort workerChloroquine and primaquineForest exposure related to mushroom collection in Ratchaburi Province; COVID-19 co-infectionZoonotic malaria6Jongwutiwes et al. (2004) [2000]Bangkok [C]P. knowlesiLM, PCRMale; 38 years-old; NRChloroquineHistory of stay in a hilly forest area in Prachuap Khiri Khan Province near the Thailand-Myanmar border; first reported human P. knowlesi case in Thailand7Nakaviroj et al. (2015) [2013]Chanthaburi [E]P. knowlesiLM, PCRMale; 58 years-old; NRArtesunateCamping in forested national park, Khao Khitchakut National Park in Chantaburi Province, bordering Cambodia; reported mosquito exposure and presence of wild long-tailed macaques8Ngernna et al. (2019) [2017–2018]Songkhla [S]P. knowlesiLM, PCRMale; 22 years-old; rubber plantation workerChloroquine and primaquineCamping out in a forest area in Ban Na Kha, Malaysia, surrounded by a wooded area populated by wild macaquesNarathiwat [S]P. knowlesiRDT, PCRMale; 45 years-old; palm plantation workerChloroquine and primaquineTravel to forested areas in Malaysia inhabited by macaquesSongkhla [S]P. knowlesiLM, PCRMale; 50 years-old; rubber plantation workerChloroquine and primaquineCross-border forest travel (Thailand-Malaysia border)Songkhla [S]P. knowlesiUnspecified, PCRFemale; 48 years-old; rubber plantation worker and non-timber forest product finderChloroquine and primaquineCross-border forest travel (Thailand-Malaysia border)Songkhla [S]P. knowlesiLM, PCRMale; 32 years-old; rubber plantation worker and non-timber forest product finderDihydroartemisinin-piperaquine and primaquineCross-border forest exposure in Malaysia (macaque-inhabited areas)Songkhla [S]P. knowlesiLM, PCRMale; 35 years-old; rubber plantation worker and wild animal hunterChloroquine and primaquineCross-border forest travel (Thailand-Malaysia border)9Sai-ngam et al. (2022) [2021]Yala [S]P. cynomolgiLM, Singleplex RT-PCRFemale; 53 years-old; rubber plantation workerChloroquine and primaquineNRP. cynomolgiLM, Singleplex RT-PCRFemale; 55 years-old; rubber plantation workerChloroquine and primaquineNRP. cynomolgi co-infection with P. vivaxLM, Singleplex RT-PCR, Multiplex RT-PCRMale; 25 years-old; Royal Thai ArmyChloroquine and primaquineProlonged forest patrol and overnight stays (military personnel); forest exposureAbbreviations: ID, identification number; LM, light microscopy; NR, not reported; PCR, polymerase chain reaction; RDT, rapid diagnostic test; RT-PCR, real-time polymerase chain reaction; [C], Central region; [E], Eastern region; [N], Northern region; [S], Southern region; [W], Western region. Case reports of human and zoonotic malaria infection in Thailand (2004–2025). Abbreviations: ID, identification number; LM, light microscopy; NR, not reported; PCR, polymerase chain reaction; RDT, rapid diagnostic test; RT-PCR, real-time polymerase chain reaction; [C], Central region; [E], Eastern region; [N], Northern region; [S], Southern region; [W], Western region. Table 2Prevalence, incidence, epidemiological characteristics, and factors associated with the occurrence of malaria in Thailand (2004–2025).Table 2IDReference [Study year]Province [Region]Population examined/Confirmed cases (n) or incidence dataSpecies distribution (% Prevalence or incidence)Diagnostic methodsCharacteristics of the study population (sex, age, occupation, immune status)Reported/suggested factors associated with disease occurrenceCross-sectional study11Putaporntip et al. (2009) [2006–2007]Tak [N]; Chanthaburi [E]; Prachuab Khirikhan [S]; Yala [S]; Narathiwat [S]1874 febrile patients examined; 1751 malaria-positive cases (93.4%)P. falciparum (30.7%), P. vivax (54.0%), P. malariae (0.20%), P. ovale (0.17%), P. knowlesi (0.60%, including mixed infections)LM, PCRPredominantly male (2.25:1); age 1–81 years (mean 25.5); Thai (56%) and cross-border migrants from Myanmar (36%) and Cambodia (8%)Cross-border migration; seasonal variation; residence in macaque-inhabited areas (P. knowlesi cases)13Kritsiriwuthinan and Ngrenngarmlert (2011) [2008]Bangkok [C]; Samut Sakhon [C]294 participantsPlasmodium spp. (1.36%)LMMales and females; age 9–46 years (median 26); predominantly Myanmar migrantsAll positive cases were male Myanmar workers; no significant association with age, gender, or province14Kitvatanachai and Rhongbutsri (2012) [2008]Kanchanaburi [W]671 asymptomatic migrant workers and 38 symptomatic patientsAsymptomatic: 1.64%, predominantly P. vivax (81.8%); Symptomatic: 35.7%, predominantly P. falciparum (80.0%)LMAsymptomatic: age 16–42 years, Female:Male (1:1.3); symptomatic: age 13–36 years, Female:Male (1.4:1)The majority of infections linked to migrants from the Mohlumyai area, Myanmar15Sermwittayawong et al. (2012) [2008–2010]Ranong [S]419 participants (171 Thai and 248 Myanmar)P. falciparum (45.35%), P. vivax (53.22%), mixed infection (P. falciparum + P. vivax) (0.95%), P. knowlesi (0.48%) by PCRLM, PCR, DNA sequencingTwo P. knowlesi cases (45-year-old Thai male and 30-year-old Myanmese male), both worked in Kawthoung district, MyanmarCross-border transmission in the Thai-Myanmar border area16Baum et al. (2015) [2012]Tak [N]219 community samples; 61 clinical patientsCommunity (qPCR): Plasmodium sp. (11.4%), P. vivax (7.7%), P. falciparum (3.65%); Clinic (qPCR): Plasmodium sp. (44.3%), P. vivax (21.3%), P. falciparum (11.5%), mixed P. vivax + P. falciparum (11.5%)LM, qPCRCommunity residents (asymptomatic survey) and symptomatic clinic patientsNR19Sermwittayawong et al. (2015) [2009–2010]Ranong [S], Yala [S]408 microscopy-confirmed malaria casesRanong: P. falciparum (46.00%), P. vivax (54.00%); Yala: P. falciparum (52.00%), P. vivax (45.00%)LM, Single nucleotide polymorphism (SNP) analysis of codon 86 in the pfmdr1 geneNRMarked geographical difference in pfmdr1 N86Y mutation frequency between Ranong and Yala20Sriwichai et al. (2017) [2011–2014]Tak (Thailand-Myanmar border) [N]621 microscopy-confirmed malaria casesP. falciparum (43.00%), P. vivax (57.00%)LMMixed Thai residents and migrants (M1, M2); median age 13 years; 47% maleP. falciparum is associated with recent migration (imported); P. vivax is associated with local vector density21Sattabongkot et al. (2018) [2015]Tak [N]3650 community residents examined; 85 sub-microscopic Plasmodium infections confirmed by LAMP and PCR (2.33%)P. vivax (52.9%), P. falciparum (30.6%), P. malariae (2.4%), mixed P. falciparum + P. vivax (4.7%), Plasmodium spp. undetermined (9.4%)LM, LAMPMale and female; age 1 month to 99 years (median 15); predominantly asymptomatic; higher prevalence in age 31–45 years; plantation workers and merchants at increased riskAsymptomatic sub-microscopic carriage; plantation and merchant occupations; specific hamlets (Nong Bua, Suan Oi); molecular detection revealed substantially higher prevalence than microscopy28Chaivisit et al. (2020) [2013–2016]Chumphon [S], Nakhon Si Thammarat [S], Krabi [S], Phang Nga [S], Phuket [S], Ranong [S], Surat Thani [S]4244 new malaria casesP. falciparum (60.13%), P. vivax (38.15%), P. malariae (0.94%), mixed P. falciparum + P. vivax (0.78%)Routine national malaria surveillance databaseThai nationals; highest incidence in males aged 15–44 years; 61.73% rubber agricultural workersIncidence associated with district, sex-age category, and year; seasonal peak (May-June); high-risk border districts near Myanmar; land-use change/deforestation29Shimizu et al. (2020) [Jan-May 2019]Surat Thani [S]9418 participants; 7034 samples (Jan) and 8671 samples (May); Infections: 0.45% in January and 0.61% in MayCombined infections: 85/15,705 (0.54%); P. falciparum (34%), P. vivax (34%), P. knowlesi (3.5%), unknown (28%)RDT, PCR, qPCRThai nationals; median age 39 years; 82.6% ≥ 15 years; 50.9% female; majority agriculture-related; mostly asymptomatic infectionsStaying outdoors at night-time; male sex; seasonal peak (May); predominantly outdoor transmission30Putaporntip et al. (2021) [2007–2018]Tak [N], Ubon Ratchathani [NE], Chanthaburi [E], Yala [S], Narathiwat [S]1359 febrile patients tested; 1180 PCR-confirmed malaria cases; P. cynomolgi co-infections (0.76% of PCR-positive cases)P. vivax (69.66%), P. falciparum (23.14%), P. knowlesi (0.34%), P. malariae (0.25%), P. ovale (0.09%), mixed P. vivax + P. falciparum (4.66%), mixed P. vivax + P. knowlesi (0.76%), mixed P. vivax + P. cynomolgi (0.59%), mixed P. vivax + P. knowlesi + P. cynomolgi (0.09%), mixed P. falciparum + P. knowlesi (0.34%), mixed P. falciparum + P. cynomolgi (0.09%)LM, PCR, DNA sequencingFebrile patients attending malaria clinics/hospitals, age 7–85 years, 79.7% male, all symptomatic; most P. cynomolgi cases were male (8/9), age 15–53 years, some lived near domesticated/wild macaquesSuggested zoonotic transmission from macaques (long-tailed and pig-tailed); residence in proximity to macaques; more cases during the rainy season; morphological similarity with P. vivax may cause misdiagnosis; cross-species transmission likely via shared Anopheles vectors31Putaporntip et al. (2022) [1996–2018]Tak [N], Ubon Ratchathani [NE], Chanthaburi [E], Yala [S], Narathiwat [S]5271 acute febrile patients tested; 4195 PCR-confirmed malaria cases; simian malaria detected in 68 patients (1.62% of PCR-positive cases)Human malaria species present: P. vivax (60.50%), P. falciparum (28.03%), P. malariae (0.1%), P. ovale curtisi (0.02%), P. ovale wallikeri (0.02%); Simian species: P. knowlesi (0.72%), P. cynomolgi (0.50%), P. inui (0.45%), P. fieldi (0.07%); Mixed infections: 10.92% double; 0.17% triple; 85.29% of simian infections were mixed (mostly with P. vivax)LM, PCR, DNA sequencingSymptomatic febrile patients attending malaria clinics/hospitals; age 1–90 years (mean 31.2 years); 69.65% male; most simian malaria cases were co-infections; P. inui patients aged 4–54 years (mean 29.6; Male:female ratio 2.17:1); P. fieldi detected only in Yala (2017–2018); many patients reported residence near macaquesSuggested zoonotic transmission from long-tailed and pig-tailed macaques; higher occurrence during rainy season; residence near macaque habitats; likely vector-mediated cross-species transmission; microscopy frequently misdiagnosed as simian species as P. vivax or P. falciparum36Aung et al. (2025b) [Mar-Apr 2025]Tak [N]300 short-term Myanmar migrants; 6 PCR-confirmed cases (2% prevalence)P. vivax (100%)Genus-specific qPCR, species-specific qPCRAge 18–78 years; 52.7% female; 71.3% Karen ethnicity; 71% no formal education; 39% daily wage labourers; all informal employment; 39% reported prior malaria; all infections asymptomatic (afebrile)Lower malaria knowledge; lower care-seeking score; majority of infected individuals were Karen ethnicity; daily wage labourers; low education level; frequent return to Myanmar (descriptive pattern); asymptomatic carriageCross-sectional study and cohort study12Jongwutiwes et al. (2011) [2008–2009]Tak [N]; Chantaburi [E]; Yala [S]; Narathiwat [S]3770 febrile patients examined; 3446 PCR-positive (91.4%)P. falciparum (45.15%), P. vivax (41.27%), P. malariae (0.15%), P. ovale (rare), P. knowlesi detected in 23 cases (0.67%, 8 monoinfections and 15 co-infections), mixed-species infections 13.26%LM, PCR, DNA sequencingPredominantly male (∼2:1)Regional and seasonal variation; higher mixed-species infections in specific provinces; P. knowlesi associated with residence in macaque-inhabited areasCase-control study10Chaveepojnkamjorn and Pichainarong (2004) [2002]Chiang Rai [N]; Kanchanaburi [W]217 confirmed malaria casesP. falciparum (60.8%), P. vivax (36.4%), mixed infection (P. falciparum + P. vivax) (2.8%)LMPredominantly male; majority < 35 years; Thai-Yai and Myanmar ethnic groupsForest residence and workplace; outdoor exposure; population mobility; low personal protectionCohort study22Lawpoolsri et al. (2019) [2011–mid-2017]Tak [N]7812/410 (5.2% cumulative incidence over 6.5 years; 527 malaria episodes)P. vivax (64.5%, 340/527 episodes), P. falciparum (34.3%, 181/527 episodes), Mixed infection (1.1%, 6/527 episodes)LM, RDTMale and female; all age groups (< 5 years to > 60 years); open community-based cohort; symptomatic and asymptomatic infections; higher recurrence among males and younger age groups (especially 6–10 years); Karen ethnicity predominant; various occupationsMale sex; young age (especially 6–10 years); Karen ethnicity; forest-related occupation; child/student status; factory and plantation work; presence of other malaria-infected household members during the same period; clustering within households; shorter recurrence interval in younger individuals; majority of recurrent episodes caused by the same Plasmodium species25Nguitragool et al. (2019) [2013–2014]Kanchanaburi [W], Ratchaburi [C]999 participants (prospective cohort; 735 PCR-detected infections)P. vivax (1.7–4.2%), P. falciparum (0–1.3%); mixed infection (6.3% of genotyped infections)qPCRMale and female; age 1–83 years (mean 23 years); predominantly agricultural border population (Thai and Karen); majority asymptomaticMalaria risk associated with rainy season, agriculture, male sex, previous clinical malaria, and travel to Myanmar; indoor residual spray (IRS) protective; infections are highly clustered with substantial asymptomatic reservoir27Yorsaeng et al. (2019) [2013–2014]Kanchanaburi [W]812 participantsP. malariae (0.25%)qRT-PCRRural village population (∼800 residents); Thai and Karen ethnic groups; agriculture main occupation; 1 asymptomatic chronic infection (41-year-old male); 1 clinical case (54-year-old female)Low-density persistent asymptomatic infection; misidentification by microscopy; potential chronic reservoir sustaining transmission at very low prevalence; challenge for malaria elimination33Gilder et al. (2025) [2012–2015]Tak [N]4352 asymptomatic pregnant womenP. vivax (59.8%), P. falciparum (6.5%), mixed P. falciparum + P. vivax (1.8%), unspeciated (31.9%)LM, qPCR, species-specific nested PCRMigrant and refugee pregnant women attending first ANC visit; median gestational age 16.5 weeks; largely asymptomatic; low seasonal transmission setting; regular biweekly malaria screeningsMiP associated with a high risk of subsequent microscopic malaria and reduced birth weight; P. falciparum sMiP associated with maternal anaemiaCohort (retrospective) study18Rattanapunya et al. (2015) [2005–2013]Tak [N]867 confirmed malaria casesP. falciparum (54.80%), P. vivax (40.40%), P. malariae (0.20%), mixed P. falciparum + P. vivax (4.60%)LMPredominantly Burmese migrants; most cases aged 19–40 years; all symptomaticHIV-malaria co-infection (prevalence 1.85%)23Kotepui et al. (2019) [2012–2018]Tak [N]971 confirmed malaria cases/95 recurrent cases (9.78%)P. vivax (74.5%), P. falciparum (25.5%)LMMale and female; age 1–91 years (mean 17.5–20 years); Thai (58.1%) and non-Thai (41.9%); majority students and farmers; cases from OPD and IPD; higher recurrence among males and the student groupMale sex; Thai nationality; student occupation; presence of headache; hematological changes after initial drug regimen (decreased neutrophils, decreased RBC/Hb, increased lymphocytes, increased platelets); recurrence associated with specific demographic and clinical characteristics26Saita et al. (2019) [2012–2017]Tak [N], Kanchanaburi [W]Provincial population (2012–2017); P. falciparum cases: 6454 (2012) to 106 (2017); P. vivax cases: 9480 (2012) to 1250 (2017) (routine surveillance)P. falciparum and P. vivax (API marked decline 2012–2017; 65.22% and 40.99% of sub-districts at elimination level for P. falciparum and P. vivax, respectively)Routine surveillance data (microscopy in hospitals/clinics; RDT in malaria posts)Predominantly Thai; majority cases aged 5–14 years (Tak) and 25–44 years (Kanchanaburi); common among agricultural workers; migrants (M1/M2)Spatial clustering along border areas; seasonal peaks (rainy season); cross-border movement and migration; agricultural/forest-related exposure; persistent transmission foci acting as reservoirs; risk of re-importationLongitudinal and ecological study17Kaewpitoon et al. (2015) [2008–2012]Buriram [NE], Surin [NE]846 reported malaria casesP. vivax (45.36%), P. falciparum (40.66%), mixed infection (8.66%), unidentified (5.32%)Secondary data from routine surveillance system (diagnostic method not specified)Predominantly males; most cases aged 31–40 years; mainly agricultural workersMalaria morbidity is associated with agricultural land use, population density, Anopheles adult density, and average annual relative humidity24Mercado et al. (2019) [2012–2015]Tak [N]526,045–618,382 (annual population); 36,536 confirmed cases (2012–2015, routine surveillance)P. vivax (61.08%), P. falciparum (35.98%), P. malariae (0.12%), mixed P. falciparum + P. vivax (0.42%), unknown (2.40%)Routine national malaria surveillance (microscopy-based confirmation; BVBD database)Male predominance; majority ≥ 15 years; Myanmar and Thai nationals; cases concentrated along Thai-Myanmar border districtsRainfall associated with total and P. vivax annual parasite incidence per 1000 population (API), higher in forested sub-districts32Pongsoipetch et al. (2024) [2011–2021]Si Sa Ket [NE], Ubon Ratchathani [NE]23,570 confirmed malaria cases included (Si Sa Ket n = 7825; Ubon n = 15,745)API for P. vivax was higher than P. falciparum; Total confirmed case decline from 1061 in 2011 (P. vivax = 881, P. falciparum = 180) to 36 in 2021 (P. falciparum = 4 confirmed cases in last 2 years)Secondary data from confirmed malaria cases by LM, RDTIndividual anonymized records of malaria cases reported between 2011 and 2021 in Si Sa Ket and Ubon Ratchathani obtained from the DVBD and actively detected cases from the investigation of transmission foci, which has been performed in Thailand since 2009Forest proximity and forest cover; cross-border mobility; mobile/migrant populations; agricultural work, rubber plantations, cassava plantations, and forest-going activities; 2014–2016 forest-related outbreak (rosewood harvesting); environmental/climatic factors34Pratumchart et al. (2025) [2012–2018]77 provinces (nationwide)31,668 confirmed malaria cases; Incidence decreased from 2.16 to 0.84 per 10,000 (P. vivax) and 2.16 to 0.13 per 10,000 (P. falciparum) between 2012 and 2018P. vivax (∼87.6%), P. falciparum (∼12.2%), mixed P. falciparum + P. vivax (∼0.1%)Routine national malaria surveillance (microscopy-based and/or RDT confirmation; BVBD database)Not individually described (secondary surveillance dataset; population-level district data, nationwide coverage)Seasonal pattern observed; environmental and climatic factors significantly associated: high-risk clusters along Thailand-Cambodia and Thailand-Myanmar borders; central Thailand low risk35Aung et al. (2025a) [2018–2023]Tak [N]13,347 febrile malaria-suspected patients; 1541 confirmed casesP. vivax (95.5.%), P. falciparum (3.2%), P. malariae (1.0%), mixed P. falciparum + P. vivax (0.2%)LM (WHO protocol); two expert confirmationsFebrile individuals presenting to malaria clinics; majority Thai (89.2%); 57.6% male; high proportion of school-aged children (32.2%); border population with frequent cross-border movementAge 5–14 years and 15–34 years; male; Myanmar nationals, other non-Thai nationals; recent travel cross-border within 2 weeks; livestock occupationAbbreviations: ID, Identification number; LM, Light microscopy; LAMP, Loop-mediated isothermal amplification; NR, Not reported; PCR, Polymerase chain reaction; qPCR, quantitative PCR; qRT-PCR, quantitative reverse transcription PCR; RDT, rapid diagnostic test; [C], Central region; [E], Eastern region; [N], Northern region; [NE], Northeastern region; [S], Southern region; [W], Western region; DVBD, the Division of Vector-borne Diseases, Department of Disease Control, Ministry of Public Health, Thailand; sMiP, submicroscopic malaria in pregnancy. Prevalence, incidence, epidemiological characteristics, and factors associated with the occurrence of malaria in Thailand (2004–2025). Abbreviations: ID, Identification number; LM, Light microscopy; LAMP, Loop-mediated isothermal amplification; NR, Not reported; PCR, Polymerase chain reaction; qPCR, quantitative PCR; qRT-PCR, quantitative reverse transcription PCR; RDT, rapid diagnostic test; [C], Central region; [E], Eastern region; [N], Northern region; [NE], Northeastern region; [S], Southern region; [W], Western region; DVBD, the Division of Vector-borne Diseases, Department of Disease Control, Ministry of Public Health, Thailand; sMiP, submicroscopic malaria in pregnancy. Prevalence and incidence patterns Longitudinal and ecological studies (n = 4), and cohort studies (n = 8) consistently demonstrated a marked reduction in malaria incidence over time. Earlier studies (2004–2012) (n = 9) frequently reported P. falciparum as the dominant or co-dominant species. National data from 2012 to 2018 showed a marked decline in P. falciparum incidence, while P. vivax became increasingly predominant (Pratumchart et al., 2025). Provincial analyses in Tak, Kanchanaburi, Si Sa Ket, and Ubon Ratchathani similarly reported sharp reductions in confirmed cases between 2011 and 2021, accompanied by a substantial reduction in P. falciparum cases. Nevertheless, P. vivax persisted as the dominant residual species in elimination-phase settings (Pongsoipetch et al., 2024). Cross-sectional and cohort studies revealed heterogeneous prevalence depending on population type and diagnostic method. Community-based surveys generally reported low prevalence (< 1–3%) by microscopy, whereas molecular methods (PCR, qPCR, LAMP) detected higher rates, including submicroscopic infections ranging from approximately 2% to > 10% in some border communities (Baum et al., 2015; Sattabongkot et al., 2018; Yorsaeng et al., 2019). In contrast, clinic-based febrile populations showed substantially higher positivity rates, often exceeding 40–90% among suspected malaria cases in earlier border-focused studies. Cohort studies further documented cumulative incidence ranging from approximately 5% over multi-year follow-up, with frequent recurrent episodes, particularly due to P. vivax (Table 2). Mixed-species infections were regularly reported, although typically at low proportions (0.1–13.0%). Zoonotic malaria was increasingly reported during the study period. The first documented human P. knowlesi infection in Thailand was reported in 2004 (Jongwutiwes et al., 2011). Subsequent molecular-based studies identified additional cases of P. knowlesi, as well as P. cynomolgi, P. inui, and P. fieldi, which often occurred as mixed infections with P. vivax. Simian malaria accounted for approximately <1.0–1.6% of PCR-confirmed cases in multi-province analyses and was frequently misdiagnosed as P. vivax or P. falciparum by microscopy (Putaporntip et al., 2021, 2022). Geographical occurrence and epidemiological patterns Although surveillance systems operate nationwide, malaria occurrence during 2004–2025 was geographically heterogeneous and predominantly localized in areas adjacent to international borders. Province-level data consistently demonstrated spatial clustering along international borders, particularly the Thailand-Myanmar and Thailand-Cambodia borders. High-burden provinces repeatedly identified across multiple study designs included Tak, Kanchanaburi, Chanthaburi, Yala, Narathiwat, Ranong, and several southern provinces (e.g. Surat Thani, Nakhon Si Thammarat, Phang Nga). Zoonotic malaria, specifically P. knowlesi and P. cynomolgi, was progressively documented in the southern provinces next to Malaysia, including Yala, Narathiwat, and Songkhla (Jongwutiwes et al., 2011; Putaporntip et al., 2021, 2022). The northeastern provinces exhibited significant reductions in incidence over the past decade, with some districts achieving elimination-level transmission (Pongsoipetch et al., 2024). The province-level occurrence of human malaria species, simian malaria parasites, and mixed infections reported in Thailand from 2004 to 2025 is shown in Fig. 2. Occurrence of Plasmodium species reported in Thailand from 2004 to 2025 according to data presented in Table 1, Table 2 The map summarizes province-level findings from included malaria studies and illustrates reported occurrence of human malaria species, simian malaria parasites, and mixed infections. Factors associated with malaria occurrence Malaria occurrence in Thailand was associated with multiple demographic, behavioral, environmental, and ecological factors across the included studies. Host-related factors reported in epidemiological analyses included male sex, younger age groups, student status, agricultural and plantation occupations, migrant status, and a history of previous malaria episodes. Recurrent malaria was more common among males, students, and individuals infected with P. falciparum in certain cohorts (Lawpoolsri et al., 2019). HIV-malaria co-infection was reported in border provinces and was associated with higher parasite density and anemia (Rattanapunya et al., 2015). Behavioral and occupational exposures consistently identified across studies included forest-related work, rubber plantation employment, hunting, mushroom collection in forested areas, military patrol activities, and overnight stays in forests (Changpradub and Mungthin, 2014; Boonyarangka et al., 2022; Sai-ngam et al., 2022). Outdoor exposure was significantly associated with malaria infection in several studies (Chaveepojnkamjorn and Pichainarong, 2004; Shimizu et al., 2020). Population mobility and migration were frequently reported, particularly along the Thailand-Myanmar, Thailand-Cambodia, and Thailand-Malaysia borders (Chaveepojnkamjorn and Pichainarong, 2004; Putaporntip et al., 2009; Sriwichai et al., 2017; Saita et al., 2019; Pongsoipetch et al., 2024). Reported environmental and ecological factors associated with malaria included proximity to forests, degree of forest cover, agricultural land use, relative humidity, and rainfall (Mercado et al., 2019; Nguitragool et al., 2019; Pongsoipetch et al., 2024). Studies of zoonotic malaria reported associations with residence or occupational activities in areas inhabited by long-tailed and pig-tailed macaques. Molecular investigations confirmed the presence of simian malaria parasites in humans in these areas (Putaporntip et al., 2009, 2021, 2022; Jongwutiwes et al., 2011; Nakaviroj et al., 2015; Ngernna et al., 2019). Leishmaniasis in Thailand (2004–2025) Study characteristics and parasite diversity In this review, the documented cases of autochthonous leishmaniasis in Thailand between 2004 and 2025, consisting of case reports (n = 15) (Table 3), cross-sectional studies (n = 4), case-control studies (n = 1), and cohort studies (n = 1) (Table 4), were identified. A total of six different species of Leishmania were reported, which included L. martiniquensis, L. orientalis, L. infantum, L. donovani, L. lainsoni, and L. major, as well as undetermined Leishmania species. Table 3Case reports of autochthonous leishmaniasis in Thailand (2004–2025).Table 3IDReference [Study year]Province [Region]Species [Clinical form]Diagnostic methodsCharacteristics of the study case (sex, age, occupation, immune status)Treatment/RelapseReported/suggested factors associated with disease occurrence37Kongkaew et al. (2007) [2005]Nan [N]Leishmania spp. [VL]LMMale; 40 years-old; Construction worker; ImmunocompetentAmp B/NoSand files, Sergentomyia spp.; DAT positive in 1 cat and 3 cows38Maharom et al. (2008) [2007]Bangkok [C]L. infantum [VL]LM, DAT, PCR, DNA sequencingMale; 66 years-old; Lumber truck driver; ImmunocompetentAmp B/NoNR39Sukmee et al. (2008) [2006]Phang Nga [S]L. martiniquensis (identified as L. siamensis) [VL]LM, DAT, PCR, DNA sequencingMale; 55 years-old; Rubber planter; ImmunocompetentAmp B/YesNR40Suankratay et al. (2010) [2009]Chanthaburi [E]L. martiniquensis [VL]LM, PCR, DNA sequencingMale; 37 years-old; Fisherman: HIV with CD4+ = 129 cells/mm3Amp B and itraconazole/NoNR41Bualert et al. (2012) [2010]Trang [S]L. orientalis (identified as L. siamensis) [CL, VL]LM, PCR, DNA sequencingFemale; 32 years-old; NA; HIV with CD4+ = 107 cells/mm3Amp B and fluconazole/NANR42Chusri et al. (2012) [2011]Songkhla [S]L. martiniquensis [CL, VL]LM, PCR, DNA sequencingMale; 46 years-old; Rubber planter; HIV with CD4+ = 175 (cells/mm3)Amp B and itraconazole/YesNRTrang [S]L. martiniquensis [CL, VL]LM, PCR, DNA sequencingMale; 30 years-old; Pet store owner; HIVwith CD4+ = 111 cells/mm3Amp B and itraconazole/YesNR43Kattipathanapong et al. (2012) [2011]Lop Buri [C]Leishmania spp. [CL]LMFemale; 3 years-old; NA; ImmunocompetentItraconazole/NoNR44Phumee et al. (2013) [2012]Chiang Rai [N]L. martiniquensis [CL]LM, PCR, DNA sequencingMale; 45 years-old; NA; HIV with CD4+ < 50 cells/mm3NA/NANR45Osatakul et al. (2014) [2010]Satun [S]L. martiniquensis [VL]LM, DAT, PCR, DNA sequencingFemale; 7 years-old; NA; ImmunocompetentAmp B/YesNR46Pothirat et al. (2014) [2012]Lamphun [N]L. martiniquensis [VL]LM, PCR, DNA sequencingMale; 52 years-old; Farmer; ImmunocompetentAmp B/YesaNR47Chiewchanvit et al. (2015) [2013]Chiang Mai [N]L. martiniquensis [CL, VL]LM, PCR, DNA sequencingMale; 48 years-old; Salesperson; HIV, CD4+ = 121 cells/mm3Amp B and itraconazole/YesNRLamphun [N]L. martiniquensis [CL, VL]LM, PCR, DNA sequencingMale; 38 years-old; Lumberjack; HIV, CD4+ = 543 cells/mm3Amp B and itraconazole/NoNR48Supsrisunjai et al. (2017) [2015]Kanchanaburi [W]L. orientalis [CL]LM, PCR, DNA sequencingFemale; 42 years-old; Housewife; HIV, CD4+ = 89 cells/mm3Amp B and itraconazole/NoNR49Jariyapan et al. (2018) [2014]Nan [N]L. orientalis [CL]LM, PCR, DNA sequencingFemale; 57 years-old; Gardener; ImmunocompetentAmp B and fluconazole/NoNR50Srivarasat et al. (2022) [2021]Chiang Rai [N]L. martiniquensis [CL, MCL, VL]LM, PCR, DNA sequencingFemale; 47 years-old; NA; HIV, CD4+ = 185 cells/mm3Amp B and itraconazole/NoNR51Anugulruengkitt et al. (2023) [2021]Nakhon Si Thammarat [S]L. orientalis [CL]LM, PCR, DNA sequencingFemale; 1.5 years-old; NA; ImmunocompetentItraconazole/NoNRAbbreviations: Amp B, amphotericin B; BM, bone marrow; CL, cutaneous leishmaniasis; DAT, direct agglutination test; ID, identification number; LM, light microscopy; MCL, mucocutaneous leishmaniasis; NA, not available; NR, not reported; PCR, polymerase chain reaction; VL, visceral leishmaniasis; [C], Central region; [E], Eastern region; [N], Northern region; [S], Southern region; [W], Western region.aIn Mano et al. (2023a, b) and Jariyapan et al. (2025). Case reports of autochthonous leishmaniasis in Thailand (2004–2025). Abbreviations: Amp B, amphotericin B; BM, bone marrow; CL, cutaneous leishmaniasis; DAT, direct agglutination test; ID, identification number; LM, light microscopy; MCL, mucocutaneous leishmaniasis; NA, not available; NR, not reported; PCR, polymerase chain reaction; VL, visceral leishmaniasis; [C], Central region; [E], Eastern region; [N], Northern region; [S], Southern region; [W], Western region. In Mano et al. (2023a, b) and Jariyapan et al. (2025). Table 4Prevalence, incidence, epidemiological characteristics, and factors associated with the occurrence of leishmaniasis in Thailand (2004–2025).Table 4IDReference [Study year]Province [Region]Population examined/Confirmed cases (n) or incidence dataSpecies distribution (% Prevalence or incidence)Diagnostic methodsCharacteristics of the study population (sex, age, occupation/immune status)Reported/suggested factors associated with disease occurrenceCross-sectional study52Manomat e al. (2017) [2015–2016]Trang [S]724 HIV-positive individuals; Leishmania infection 25.1%L. orientalis (identified as L. siamensis) (40.8%), L. martiniquensis (26.5%), L. donovani complex (20.4%), L. lainsoni (10.2%), L. major (2.1%)DAT, nested ITS1 PCR, DNA sequencingHIV-positive adults (> 18 years) (mean age 43.6 ± 8.5 years); Male and female (∼1:1); on ART follow-up; varied occupations (agriculture common); majority CD4+ > 500 cells/μlLiving in stilt houses (independent risk factor); CD4+ < 500 cells/μl (especially < 200 cells/μl); detectable HIV viral load (associated with PCR positivity); non-injection drug use (associated with seropositivity); possible underdiagnosis because asymptomatic infection was common56Jundang et al. (2024) [2020–2021]Satun [S]650 HIV-positive individuals; Leishmania infection 8.6%L. orientalis (70.0%), L. martiniquensis (20.0%), L. donovani complex (10.0%)DAT, nested ITS1 PCR, DNA sequencingHIV-infected adults ≥ 18 years (mean age 43.6 ± 10.6 years); Male and female (∼1:1); Most on HAART (∼99%); Varied occupations (labor common); Majority CD4 ≥ 500 cells/mm3; Most viral load < 50 copies/mlIncreasing age; intravenous drug use; CD4 count < 500 cells/mm3; viral load ≥ 50 copies/ml; other factors (sex, education, occupation, opportunistic infection, bednet use, animal raising, housing type) not independently associated after multivariate adjustment57Piyaraj et al. (2024) [Jun-Aug 2022 (baseline), Nov-Dec 2022 and July-Aug 2023 (follow-up)]Trang [S]500 blood donors; Leishmania infection 19.0%L. martiniquensis (98.5%), L. donovani complex (1.5%)DAT, nested ITS1 PCR, DNA sequencingImmunocompetent blood donors ≥ 18 years (mean age 37.1 ± 10.9 years); Male and female (∼1:1); Varied occupations (government officers, farmers, merchants, employees, and students); HIV-, HBV-, HCV-, and syphilis-negative per national blood bank screening; Without significant underlying immunosuppressionLiving in stilt houses independently associated with infection; dog ownership significant in univariate analysis but not independently associated after adjustment; other factors (sex, age, occupation, drug use, travel history, underlying diseases, bednet use, proximity to forest, plantation, corral, nighttime outdoor activities) not significantly associated; environmental exposure under stilt houses suggested as favorable for sand fly vectors; high prevalence of asymptomatic carriage suggests potential transfusion transmission risk54Sriwongpan et al. (2021) [Sep-Nov 2015]Chiang Rai [N]392 immunocompetent individuals; Leishmania infection 7.1%L. martiniquensis (4.8%), L. orientalis (57.1%), Leishmania spp. (38.1%)DAT, nested ITS1-PCR, DNA sequencingImmunocompetent adults; Male and female (∼2:1); Mean age 30.78 years in infected group and 19.40 years in non-infected group; Majority of students (79.8%), predominantly hill tribe populations, most without comorbidities, residents from both urban vocational school settings and rural mountainous communitiesFemale sex; increasing age; animal enclosures within 200 m of house; domestic animals in housing area; exposure to termite mounds; dark housing (urban site); not avoiding exposure to carrier animals; rural residence (mountainous area); evidence of infected sand flies (P. stantoni, S. gemmea) and black rats (possible reservoir)Case-control study53Charoensakulchai et al. (2020) [2015–2016]Trang [S]526 HIV-positive individuals; Leishmania infection 12.0%L. orientalis (identified as L. siamensis) (12.0%), L. martiniquensis (4.6%), L. donovani complex (4.4%)DAT, nested ITS1 PCR, DNA sequencingHIV-infected adults ≥ 18 years attending HIV clinic (mean age 43.85 years); Male and female (∼1:1); Varied occupationsIntravenous drug use (associated with L. orientalis, possible transmission via shared syringes); female sex (L. martiniquensis; possibly related to differential vector exposure); recreational drug use; presence of comorbidities (immune dysregulation); opportunistic infections; CD4+ 200–500 cells/mm3; not using insect repellent (increased vector exposure); underlying immunosuppression in HIV-infected individuals; vector exposure in endemic areasCohort study55Bualert et al. (2024) [2015–2016 (baseline), 2018–2019 (follow-up)]Trang [S]643 HIV-positive individuals at baseline, 506 followed up; Cumulative incidence 3.2%; Cumulative persistence 3.7%Incidental species: L. orientalis; Persistent species: L. donovani complex; Baseline-positive species included L. orientalis, L. martiniquensis, L. donovani complex, L. lainsoni, Leishmania spp.DAT, nested ITS1 PCR, DNA sequencingHIV-infected adults ≥ 18 years (mean ∼44 years); Male and female (∼1:1); All asymptomatic and on HAART; Varied occupations (agriculture common); Majority undetectable viral load; Varied CD4 levelsIncreasing age associated with incident infection; no significant association with sex, CD4 count, viral load, housing, animal exposure, or bednet use; asymptomatic infection was common; ongoing endemic transmission suggestedAbbreviations: DAT, direct agglutination test; ID, identification number; NR, not reported; PCR, polymerase chain reaction; [N], Northern region; [S], Southern region. Prevalence, incidence, epidemiological characteristics, and factors associated with the occurrence of leishmaniasis in Thailand (2004–2025). Abbreviations: DAT, direct agglutination test; ID, identification number; NR, not reported; PCR, polymerase chain reaction; [N], Northern region; [S], Southern region. Prevalence and incidence patterns Autochthonous leishmaniasis cases were continuously reported in Thailand throughout the study period. Early reports described sporadic cases of VL, initially identified in immunocompetent individuals. However, from 2010 onwards, an increasing proportion of cases occurred among PLHIV, particularly those with low CD4+ T-cell counts (< 200 cells/mm3) (Suankratay et al., 2010; Bualert et al., 2012; Chusri et al., 2012; Phumee et al., 2013; Chiewchanvit et al., 2015; Supsrisunjai et al., 2017; Srivarasat et al., 2022). Across all studies, L. martiniquensis and L. orientalis were the most frequently detected species, followed by members of the L. donovani complex (L. infantum), while other species such as L. lainsoni and L. major were reported less frequently (Manomat et al., 2017). Relapse was documented in several cases, particularly among PLHIV, and amphotericin B was the drug of choice for treatment (Sukmee et al., 2008; Chusri et al., 2012; Osatakul et al., 2014; Pothirat et al., 2014; Chiewchanvit et al., 2015). Population-based studies further demonstrated that leishmaniasis in Thailand is not limited to sporadic clinical cases but shows characteristics of endemic transmission in specific regions. Among PLHIV, prevalence ranged from 8.61% to 25.1% in southern provinces, specifically in Trang and Satun, highlighting a geographically localized finding (Manomat et al., 2017; Charoensakulchai et al., 2020; Jundang et al., 2024), with cumulative incidence reported at 3.2% in a longitudinal study (Bualert et al., 2024). In contrast, studies in immunocompetent populations revealed prevalence rates of 7.1% in northern Thailand (Sriwongpan et al., 2021) and as high as 19.0% among blood donors in southern Thailand (Piyaraj et al., 2024). Asymptomatic infections were frequently detected across multiple studies involving both PLHIV and immunocompetent participants. Geographical occurrence and epidemiological patterns Reported leishmaniasis cases and epidemiological studies were primarily concentrated in southern and northern Thailand. In southern Thailand, particularly Trang Province, both clinical case reports and high prevalence studies in PLHIV and blood donors were reported (Piyaraj et al., 2024). Autochthonous cases and evidence of ongoing transmission were also reported in other southern provinces, including Songkhla, Nakhon Si Thammarat, and Satun (Chusri et al., 2012; Osatakul et al., 2014; Anugulruengkitt et al., 2023; Jundang et al., 2024). In northern Thailand, provinces such as Nan, Chiang Rai, Lamphun, and Chiang Mai reported both symptomatic and asymptomatic infections (Kongkaew et al., 2007; Pothirat et al., 2014; Chiewchanvit et al., 2015; Jariyapan et al., 2018). Entomological studies in Chiang Rai discovered infected sandflies (Phlebotomus stantoni, Sergentomyia gemmea) and black rats as potential reservoirs (Sriwongpan et al., 2021). Central, eastern, and western regions reported sporadic autochthonous cases; however, large-scale prevalence studies remain limited in these areas (Maharom et al., 2008; Suankratay et al., 2010; Kattipathanapong et al., 2012; Supsrisunjai et al., 2017). The province-level occurrence of Leishmania species reported in Thailand from 2004 to 2025 is summarized in Fig. 3. Occurrence of Leishmania species reported in Thailand from 2004 to 2025 according to data presented in Table 3, Table 4 The map summarizes province-level findings from included leishmaniasis studies. Factors associated with leishmaniasis occurrence Reported host-related factors included HIV infection, low CD4+ T-cell counts, HIV viral load, increasing age, and intravenous drug use. Immunosuppression was strongly associated with symptomatic disease and relapse (Charoensakulchai et al., 2020; Jundang et al., 2024). Environmental and behavioral factors were identified in multivariate analyses. Living in stilt houses was identified as an independent risk factor in multiple studies (Manomat et al., 2017; Piyaraj et al., 2024). Additional factors included proximity to animal enclosures, domestic animal ownership, exposure to termite mounds, dark housing conditions, rural or mountainous residence, and inadequate vector avoidance behaviors. Evidence of infected sand fly vectors and potential animal reservoirs supported zoonotic and vector-borne transmission pathways (Sriwongpan et al., 2021). Moreover, asymptomatic infection was a common finding across both PLHIV and immunocompetent populations (Manomat et al., 2017; Bualert et al., 2024). Cross-disease synthesis of malaria and leishmaniasis in Thailand According to data in Table 1, Table 2, Table 3, Table 4, seven provinces, including Phang Nga, Songkhla, Nakhon Si Thammarat (Southern region), Bangkok (Central region), Chanthaburi (Eastern region), Chiang Rai (Northern region), and Kanchanaburi (Western region), had reported occurrences of both malaria and leishmaniasis across the overall review period (Fig. 4). Although malaria surveillance data indicate a broader nationwide distribution, province-level evidence from included studies suggests co-occurrence at a relatively coarse spatial scale. Several of these provinces, particularly Chiang Rai, Kanchanaburi, and Chanthaburi, are border areas with documented malaria transmission and reported leishmaniasis cases. However, no confirmed malaria-Leishmania co-infection cases were identified in the reviewed studies. Therefore, the observed patterns reflect province-level co-occurrence rather than confirmed transmission within the same populations or ecological settings. Both diseases are associated with forested and plantation-based environments, which may provide shared ecological conditions for vectors and potential zoonotic reservoirs, supporting sustained transmission. Individuals engaged in forest-related activities, migrant workers, and marginalized populations may be at increased risk of exposure. Additionally, immunocompromised people (e.g. PLHIV) may be more susceptible to severe disease and potential undiagnosed. Forest-related occupations (e.g. rubber tappers, forest workers) and cross-border population mobility were consistently reported as important risk factors associated with increasing exposure in endemic areas (Table 5). Provinces with reported occurrence of both malaria and autochthonous leishmaniasis in Thailand (2004–2025). Provinces highlighted in red indicate provinces where both diseases were independently reported in the included studies during the overall review period (Table 1, Table 2, Table 3, Table 4; Fig. 2, Fig. 3). This figure illustrates province-level co-occurrence based on aggregated reports from different study periods and does not imply confirmed co-infection, year-to-year temporal overlap, or shared transmission within the same populations. Table 5Cross-disease synthesis of malaria and leishmaniasis in Thailand: provinces with reported occurrence of both diseases, ecological drivers, at-risk populations, and occupation and mobility-related exposures.Table 5FeatureCross-disease synthesisProvinces with reported occurrence of both diseasesSeven provinces with reported occurrence of both diseases across the overall review period: Phang Nga, Songkhla, and Nakhon Si Thammarat (Southern region); Bangkok (Central region); Chanthaburi (Eastern region); Chiang Rai (Northern region); and Kanchanaburi (Western region)Ecological driversBoth diseases have been commonly reported in association with forested and plantation-based ecosystems, which provide shared ecological conditions for vectors and potential zoonotic reservoirsAt-risk populationsPopulations potentially at increased risk include migrant workers, displaced and marginalized communities, individuals with frequent forest exposure, and immunocompromised individuals (e.g. PLHIV)Occupation and mobility-related exposuresForest-related occupations (e.g. rubber tappers, forest workers) and cross-border population mobility were consistently identified as potential exposure-related factors Cross-disease synthesis of malaria and leishmaniasis in Thailand: provinces with reported occurrence of both diseases, ecological drivers, at-risk populations, and occupation and mobility-related exposures. Discussion This systematic review synthesizes two decades of evidence on the prevalence, and epidemiological characteristics of malaria and leishmaniasis in Thailand. The findings demonstrate that despite Thailand’s substantial progress toward malaria elimination, persistent transmission foci, asymptomatic reservoirs, and the emergence of zoonotic Plasmodium species continue to challenge elimination goals. In parallel, leishmaniasis, previously regarded as a rare or imported disease, has shown sustained autochthonous transmission, expanded geographical range, and increased clinical diversity, supporting its reclassification as an endemic infection in Thailand. Although these two vector-borne diseases differ in historical endemicity and transmission dynamics, evidence from the included studies indicates province-level co-occurrence, together with shared ecological, occupational, and cross-border determinants. It is important to note that the evidence base is not balanced across the two diseases. Malaria transmission patterns are informed by systematic, nationwide surveillance that captures trends across all 77 provinces. In contrast, the documented distribution of leishmaniasis is likely underestimated, as it relies on focal research efforts and clinical recognition of a relatively ‘new’ endemic threat. Consequently, the reported ‘absence’ of leishmaniasis in specific regions should be interpreted with caution, as it may reflect a lack of targeted screening rather than true non-endemicity. This asymmetry in the evidence base may influence the apparent province-level co-occurrence between the two diseases, potentially leading to overestimation in provinces with active leishmaniasis surveillance and reporting (e.g. Trang) and underestimation in areas where systematic screening is lacking. Malaria transmission in Thailand from 2004 to 2025 remained heavily concentrated along international borders, particularly the Thailand-Myanmar, Thailand-Malaysia and Thailand-Cambodia borders. These patterns align with national surveillance data and regional assessments showing that border areas characterized by intense population mobility, forested landscapes, and limited healthcare access, remain malaria hotspots in the Greater Mekong Subregion (Geng et al., 2019; Karnchaisri et al., 2024; Pratumchart et al., 2025). Plasmodium vivax was the dominant species in most prevalence studies, particularly after 2012, accounting for more than half of malaria infections in multiple large-scale surveys. This transition reflects the success of artemisinin-based combination therapies and intensified malaria control programmes targeting P. falciparum. However, the biological characteristics of P. vivax, including hypnozoite-induced relapse, asymptomatic carriage, and lower detectability by routine diagnostics, pose a substantial obstacle to elimination. As documented in Thailand and other GMS settings, asymptomatic and recurrent P. vivax infections among migrants, forest workers, and border populations constitute a persistent silent reservoir capable of sustaining transmission despite low reported incidence (Howes et al., 2016; Villasis et al., 2022). Also, zoonotic malaria represents an additional challenge to malaria elimination in Thailand. Although zoonotic infections account for a relatively small proportion of reported cases, P. knowlesi has been sporadically detected across central, eastern, and southern Thailand, with clustering in provinces bordering Malaysia. Molecular surveys have further identified P. cynomolgi, P. inui, and mixed simian-human infections, indicating that the diversity of simian malaria parasites circulating in Thailand is broader than previously recognized (Putaporntip et al., 2021, 2022; Hmaidee et al., 2025). The epidemiological patterns observed in Thailand are broadly consistent with those in neighboring countries (Myanmar, Lao PDR, Cambodia, and Malaysia), supporting the regional context of our findings. Across the Greater Mekong Subregion, declining transmission has been accompanied by a shift from P. falciparum to P. vivax predominance, as reported in Myanmar, Lao PDR, and Cambodia (Sandfort et al., 2020; Byrne et al., 2022; Legendre et al., 2023). Residual transmission in these settings is increasingly focal and concentrated in forested and border areas, where asymptomatic and submicroscopic infections act as persistent reservoirs, particularly among mobile and forest-exposed populations (Chaumeau et al., 2019; Byrne et al., 2022; Schneider et al., 2023; Rotejanaprasert et al., 2024). Myanmar remains an important source of cross-border transmission into Thailand, with sustained P. falciparum circulation in forested and conflict-affected areas (Legendre et al., 2023) whereas Cambodia shows similar challenges to Thailand, with P. vivax posing a major barrier to elimination due to relapse and asymptomatic carriage (Siv et al., 2016; Sandfort et al., 2020). Malaysia has reported zero indigenous P. falciparum and P. vivax malaria cases for seven consecutive years. However, malaria epidemiology in Malaysia is now dominated by zoonotic transmission, especially P. knowlesi (Raja et al., 2020; Lai et al., 2021). Recently, a systematic review by Ahebwa et al. (2025) has identified male gender, adult age, forest-related occupations, mobility, and widespread misdiagnosis as consistent determinants of zoonotic malaria, with macaque species, such as Macaca nemestrina and M. fascicularis, serving as major reservoirs for P. knowlesi, P. inui, and P. cynomolgi. Recent entomological evidence has suggested that Anopheles mosquitoes within the Leucosphyrus Group may serve as competent vectors for zoonotic simian malaria, potentially facilitating ongoing transmission of P. inui and P. cynomolgi between vectors and macaque hosts (Jeyaprakasam et al., 2023). These infections were consistently associated with forest activities, agricultural or plantation work, and proximity to macaque habitats, demonstrating the importance of zoonotic spillover at the human-animal-environment interface. It should be noted that P. knowlesi is frequently misdiagnosed due to its morphological similarities to other species. It resembles the early trophozoite stages of P. falciparum and the later trophozoite and schizont stages of P. malariae (Lee et al., 2009). Additionally, previous studies have documented human infections with P. cynomolgi that were initially misidentified as P. vivax by microscopy but were later confirmed by PCR (Sai-ngam et al., 2022). The frequent misdiagnosis of P. knowlesi by light microscopy suggests that the true burden of zoonotic malaria may be underestimated (Singh and Daneshvar, 2013; Imwong et al., 2019; Putaporntip et al., 2021, 2022; Karnchaisri et al., 2024). In contrast to malaria, leishmaniasis has historically been considered an imported or rare disease in Thailand. However, evidence synthesized from the present review indicates sustained autochthonous transmission across northern, southern, and central regions of the country. Leishmania martiniquensis and L. orientalis have emerged as the predominant causative agents. Prevalence studies further revealed substantial levels of asymptomatic or subclinical infection, especially among PLHIV in southern Thailand (Manomat et al., 2017; Jundang et al., 2024), suggesting that clinically recognized cases represent only a small fraction of the true disease burden. Across studies, infection risk has been consistently associated with environmental and housing-related factors, such as stilt houses, proximity to animal enclosures, termite mounds, and domestic animals, that facilitate sand fly breeding and sustained human-vector contact. Specifically, termite mounds have been identified as an independent risk factor for leishmaniasis since they serve as ideal breeding and resting sites for sand fly vectors. Examples are P. argentipes and S. punjabensis in Sri Lanka (Wijerathna and Gunathilaka, 2020) and P. martini in East Africa (Hassaballa et al., 2021). Termite mounds provide stable micro-environmental conditions, such as humidity, regulated temperature, and protection from environmental stressors, that support the survival and development of immature sand fly stages (Wijerathna and Gunathilaka, 2020; Hassaballa et al., 2021). These conditions have similarly been identified as key risk factors for ongoing transmission in other endemic regions (Calderon-Anyosa et al., 2018; O'Brien et al., 2024). These findings indicate that leishmaniasis in Thailand is now established as an endemic disease with complex eco-epidemiological profiles. It is consistent with global trends in which ecological change, host vulnerability, and parasite adaptation drive the emergence in non-classical endemic areas (Riebenbauer et al., 2024). The coexistence of L. martiniquensis and L. orientalis underscores an underexplored issue in global leishmaniasis epidemiology, that is, the emergence of regionally adapted Leishmania species with overlapping but non-identical transmission cycles. Evidence suggests that L. martiniquensis may have a broader host range and zoonotic potential, supported by reports of infection in rodents, domestic animals, and multiple sand fly species (Kongkaew et al., 2007; Sriwongpan et al., 2021). In contrast, the transmission ecology of L. orientalis remains poorly defined. The identification of competent vectors responsible for the transmission of L. martiniquensis and L. orientalis remains unresolved. While phlebotomine sand flies are classically recognized as vectors of Leishmania spp. (Shaw, 2025), definitive evidence identifying competent vectors for L. martiniquensis and L. orientalis in Thailand is still lacking. Experimental studies demonstrated that L. orientalis could establish infection in Culicoides sonorensis, a permissive biting midge vector, whereas no infection was observed in Lutzomyia longipalpis sand flies (Chanmol et al., 2019). Complementing these findings, natural infection with L. martiniquensis has been detected in C. peregrinus (Diptera: Ceratopogonidae), suggesting that biting midges may serve as potential vectors for Mundinia-associated leishmaniasis (Kaewmee et al., 2023). However, vector competence and transmission capability under natural conditions have not yet been conclusively demonstrated. Given that Mundinia species exhibit ecological characteristics distinct from classical Leishmania, comprehensive entomological and reservoir investigations are essential. These uncertainties highlight the importance of a One Health approach, as the transmission of Leishmania in Thailand likely involves complex interactions among human, animal, and vector populations. The presence of multi-species endemicity in Thailand therefore calls for flexible, ecology-informed control strategies tailored to emerging Leishmania species rather than reliance on paradigms derived from traditional endemic settings. Despite these complexities, advances in molecular diagnostics with high sensitivity and specificity are now available and provide critical tools for surveillance and species differentiation in Thailand (Jariyapan et al., 2021; Mano et al., 2025). One of the most important findings of this review is identification of seven provinces with reported occurrences of both malaria and leishmaniasis across the overall review period. These provinces several ecological and socio-economic characteristics, including forested landscapes, plantation-based livelihoods, border proximity, population mobility, and marginalized communities. However, because the included studies were conducted during different study periods and varied in geographical coverage, these findings should be interpreted as province-level co-occurrence based on aggregated evidence rather than confirmed year-to-year temporal overlap, co-infection, or transmission within the same populations or local transmission settings. Although direct evidence of Plasmodium-Leishmania co-infection in Thailand remains limited, individuals residing or working in these areas may experience repeated exposure to both Anopheles mosquitoes and leishmaniasis vectors, especially during evening outdoor activities (Esayas et al., 2024; Msellemu et al., 2024). While malaria and leishmaniasis differ in transmission dynamics and parasite biology, accumulating evidence indicates that HIV infection increases susceptibility to both diseases through impaired host immunity. In leishmaniasis, effective parasite control depends on Th1-mediated cellular immunity (e.g. IFN-γ and IL-12) required for macrophage activation and intracellular parasite killing. This response is markedly compromised in PLHIV due to CD4+ T-cell depletion and cytokine dysregulation (Costa-da-Silva et al., 2022), and immunocompromising conditions may further increase susceptibility and exacerbate clinical outcomes in cases of concurrent or sequential infections (Silva-Freitas et al., 2025). A similar immunological impairment has been described in malaria, where HIV-associated CD4+ T-cell depletion and immune dysregulation reduce parasite clearance and impair the acquisition and maintenance of effective antimalarial immunity (Figueroa-Romero et al., 2024). Consistent with these findings, studies from endemic areas along the Thailand-Myanmar border have shown that PLHIV have higher parasite densities and an increased risk of severe malaria compared to HIV-negative individuals (Rattanapunya et al., 2015). These findings suggest that HIV may represent a shared risk factor for both leishmaniasis and malaria by impairing cell-mediated and regulatory immune responses, consequently increasing susceptibility and disease severity in settings where both diseases have been reported. This pattern also underscores potential diagnostic and surveillance gaps, as febrile illnesses in malaria-endemic settings may be presumptively attributed to malaria, leading to delayed recognition of leishmaniasis, particularly cutaneous or atypical forms (Stoler and Awandare, 2016). As malaria elimination progresses and case numbers decline, other vector-borne diseases occupying similar ecological niches may become increasingly visible. In this post-elimination context, however, diagnostic overshadowing may persist, whereby healthcare providers continue to prioritize malaria in the differential diagnosis of febrile illness, potentially delaying recognition of other infections such as leishmaniasis. Human Plasmodium-Leishmania co-infection has been documented for several decades. The earliest report originated from Sudan between 1933 and 1936, when up to 30% of patients with VL were infected with malaria (Henderson, 1937). Since then, natural co-infections have been reported across Africa and Asia, including Sudan, Ethiopia, Kenya, Uganda, India, Nepal, and Malaysia (reviewed by Ornellas-Garcia et al., 2023). In Thailand, the presence of macaque reservoirs associated with simian malaria and animal reservoirs implicated in Leishmania transmission further illustrates the ecological complexity of shared transmission environments involving both diseases (Bertram et al., 2024; Tiffin et al., 2025). Although asymptomatic infection is highlighted as a shared challenge, its definition and epidemiological implications differ between malaria and leishmaniasis. In malaria, asymptomatic infection typically refers to the presence of circulating parasites (parasitemia) without overt clinical symptoms, particularly in individuals without recent antimalarial treatment. These infections are highly prevalent in malaria-endemic areas and are frequently detected in individuals who have developed partial immunity because of repeated exposure. Asymptomatic carriers are well-recognized as a significant silent reservoir contributing to sustaining transmission because asymptomatic carriers do not seek treatment, allowing the parasites to persist in their blood and be transmitted to mosquitoes (Mazigo et al., 2025). In contrast, asymptomatic leishmaniasis generally describes individuals with evidence of infection in the absence of clinical disease, often identified through serological or molecular methods. However, the role of such individuals in sustaining transmission remains less clearly defined and may vary depending on parasite species, host immunity, and vector dynamics (Pederiva et al., 2023). Therefore, while both conditions involve subclinical infection, their implications for disease control and surveillance are not directly comparable. This distinction further highlights the limitations of disease-specific surveillance approaches. For malaria, residual transmission driven by asymptomatic carriers of P. vivax and zoonotic parasites necessitates enhanced molecular surveillance, radical cure strategies, and strengthened cross-border collaboration. Reliance on microscopy alone is insufficient to detect low-density and simian infections (Putaporntip et al., 2021, 2022; Cui et al., 2022; Karnchaisri et al., 2024). For leishmaniasis, control relies primarily on early detection, vector surveillance, and reservoir management. Ultimately, this review highlights the interconnected roles of human, animal, and environmental factors in the transmission of both diseases. Specifically, zoonotic reservoirs (e.g. macaques for simian malaria and black rats as potential animal reservoirs for Leishmania), vector ecology, and shared environmental conditions such as forested and plantation areas were consistently identified across studies, alongside human behavioral risk factors. These shared determinants underscore the importance of integrated, cross-disease surveillance approaches within a One Health framework, particularly in areas where both diseases have been reported. Future studies incorporating finer-scale epidemiological data and sub-provincial analyses are needed to better characterize shared transmission patterns and potential individual-level co-exposure. Limitations. This review integrates diverse study designs over a 20-year period, providing a comprehensive overview of malaria and leishmaniasis epidemiology in Thailand. However, in case-control studies, participants were selected based on known infection status. Such studies were valuable for identifying associated risk factors, parasite species distribution, and epidemiological patterns among confirmed cases, but they do not accurately reflect true population-level prevalence. Since cases were pre-identified, the proportion of infected individuals could not be interpreted as representative of the general community. Consequently, estimates derived from these studies may overestimate or misrepresent the actual burden of malaria in the broader population. Nevertheless, these studies provided important insights into transmission areas and key environmental and behavioral risk factors associated with infection. A primary limitation of this review is the structural asymmetry in the evidence base. The malaria data are predominantly surveillance-oriented, providing a high degree of confidence in reported incidence declines. Conversely, leishmaniasis data are more limited and heterogeneous, often restricted to specialized medical centers or specific provinces like Trang and Chiang Rai. This heterogeneity limits our ability to compare the true population-level burden of the two diseases directly. The temporal overlap between malaria and leishmaniasis could not be assessed at a year-to-year level because the included studies covered different study periods. Therefore, the observed co-occurrence should be interpreted as aggregated evidence rather than confirmed concurrent transmission. Furthermore, variability in diagnostic methods across studies might have affected the accuracy and comparability of reported prevalence. Some studies relied primarily on light microscopy RDTs, or LAMP, which have lower sensitivity for detecting low-parasitemia infections compared with molecular techniques such as PCR-based methods. For leishmaniasis, most prevalence studies were conducted among PLHIV, potentially limiting generalizability to the general population. Another important limitation is the potential under-detection of asymptomatic Leishmania infections. Publication bias toward unusual or severe cases may also have influenced the apparent reported occurrence of both diseases. Importantly, given the asymmetry in the evidence base between malaria and leishmaniasis, the apparent absence of reported leishmaniasis cases in many provinces should not be interpreted as a true absence of the disease, but rather as a reflection of fragmented and uneven surveillance systems. This limitation may contribute to under-detection in areas without active screening, while potentially inflating the apparent concentration of cases in provinces with more intensive or targeted surveillance. Province-level analysis may overestimate apparent co-occurrence and cannot confirm whether both diseases occur within the same populations or ecological settings. Consequently, the currently available data may not fully capture the true epidemiological extent of leishmaniasis or the extent of province-level co-occurrence in reported malaria and leishmaniasis cases in Thailand. Conclusion In summary, this systematic review of evidence from 2004 to 2025 demonstrates that while Thailand is progressing toward malaria elimination, the epidemiological landscape is increasingly complicated because of persistent P. vivax transmission, asymptomatic reservoirs, and the emergence of zoonotic simian malaria parasites. Simultaneously, leishmaniasis has transitioned from a perceived rarity to an established endemic disease, characterized by reported occurrence across multiple regions in Thailand and evidence of substantial subclinical infections, particularly among immunocompromised populations. A key finding of this review is the documented occurrence of both diseases at the provincial level, associated with shared ecological conditions, forest-related occupational exposures, and cross-border population mobility. Although confirmed malaria-Leishmania co-infections have not yet been documented in Thailand, these findings suggest the need for increased clinical awareness and strengthened surveillance in areas where both diseases have been reported. The lack of reported co-infections may partly reflect diagnostic overshadowing, in which malaria is prioritized in the diagnostic workup of febrile illness, thus delaying the detection of leishmaniasis. Ultimately, the convergence of these shared epidemiological and ecological characteristics underscores the limitations of disease-specific control programmes. To sustain progress toward malaria elimination while addressing the growing burden of leishmaniasis, Thailand should adopt integrated surveillance and control strategies grounded in a One Health framework. This approach should link human clinical data with veterinary and entomological surveillance to manage zoonotic reservoirs and environmental risk factors effectively. In provinces reporting both malaria and leishmaniasis, clinicians should consider leishmaniasis in the differential diagnosis of patients presenting with persistent febrile illness, compatible clinical manifestations, or relevant environmental and occupational exposures. Furthermore, because both infections may present with relapse or persistent asymptomatic infection in certain patient populations, surveillance strategies should extend beyond passive hospital-based reporting to include targeted active and molecular surveillance where appropriate. Ethical approval This study was exempted by the ethics committee of the Faculty of Medicine, Chulalongkorn University (COE No. 043/2025). CRediT authorship contribution statement Warachaya Apajamjarut: Methodology, Investigation, Formal analysis, Data curation, Visualization, Writing - original draft, Writing - review & editing. Nalin Siriwongsanon: Methodology, Investigation, Formal analysis, Data curation, Visualization, Writing - original draft, Writing - review & editing. Patanin Tonpon: Methodology, Investigation, Formal analysis, Data curation, Visualization, Writing - original draft, Writing - review & editing. Lapatrada Boonlertworakul: Methodology, Investigation, Formal analysis, Data curation, Visualization, Writing - original draft, Writing - review & editing. Ruamporn Joosiriwong: Methodology, Investigation, Formal analysis, Data curation, Visualization, Writing - original draft, Writing - review & editing. Baby Kyi Soe: Formal analysis, Data curation, Writing - original draft, Writing - review & editing. Saowalak Kaewmee: Data curation, Writing - review & editing. Jassada Saingamsook: Data curation, Writing - review & editing. Catherine Walton: Writing - review & editing. Sung Jae Lee: Writing - review & editing. Chunqing Lin: Writing - review & editing. George Dimopoulos: Writing - review & editing. Narissara Jariyapan: Conceptualization, Methodology, Investigation, Formal analysis, Data curation, Visualization, Funding acquisition, Project administration, Resources, Writing - original draft, Writing - review & editing. Statement on the use of AI-assisted technologies The authors used QuillBot (https://quillbot.com/) only to improve the readability and quality of the English language in this manuscript. This tool was not used to generate scientific content, analyze data, or influence the interpretation of results. The authors take full responsibility for the content of this article. Funding This study was supported by Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, grant number RA-MF-02/69. Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Acknowledgements We thank Assist. Prof. Dr Phichayut Phinyo, Department of Biomedical Informatics and Clinical Epidemiology (BiocE), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand, for his suggestion. We also thank the Cutting-edge, Customized, and Comprehensive (CCC) HIV Capacity Building Program for Vietnam and Thailand (D43TW012489; 2024–2028) for supporting the collaborative research environment. Footnotes Supplementary data to this article can be found online at https://doi.org/10.1016/j.crpvbd.2026.100386. A Supplementary data The following is the Supplementary data to this article: Multimedia component 1 Data availability All data generated or analyzed during this study are included in this published article and its supplementary files. References Associated Data Supplementary Materials Multimedia component 1 Data Availability Statement All data generated or analyzed during this study are included in this published article and its supplementary files.